Belldegrun Arie
SEC insider (Form 3/4/5 filer). CIK 0001296549. Director at UroGen Pharma Ltd. (URGN) and 2 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Jun 22, 2026. Located in PRINCETON, NJ.
Companies Belldegrun Arie has filed insider reports for
- UroGen Pharma Ltd. (URGN): Director
- Allogene Therapeutics, Inc. (ALLO): Director
- Kronos Bio, Inc. (KRON): Director
Belldegrun Arie
CIK: 0001296549
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 22, 2026URGN
UroGen Pharma Ltd.
AwardDirectStock Option (right ot buy)
20K shares- - Feb 2, 2026ALLO
Allogene Therapeutics, Inc.
AwardDirectRestricted Stock Unit
263K shares- - Feb 2, 2026ALLO
Allogene Therapeutics, Inc.
AwardDirectStock Option (Right to buy)
929.9K shares- - Aug 26, 2025URGN
UroGen Pharma Ltd.
AwardDirectStock Option (right ot buy)
20K shares- - Jun 20, 2025KRON
Kronos Bio, Inc.
Tender OfferIndirect679.6K shares at avg. $0.57$387K - Jun 20, 2025KRON
Kronos Bio, Inc.
Tender OfferIndirect2.8M shares at avg. $0.57$1.6M - Jun 20, 2025KRON
Kronos Bio, Inc.
DispositionDirectStock Option (Right to Buy)
20.6K shares- - Jun 20, 2025KRON
Kronos Bio, Inc.
DispositionDirectStock Option (Right to Buy)
34K shares- - Jun 20, 2025KRON
Kronos Bio, Inc.
DispositionDirectStock Option (Right to Buy)
34K shares- - Jun 20, 2025KRON
Kronos Bio, Inc.
DispositionDirectStock Option (Right to Buy)
34K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 22, 2026 |  URGN UroGen Pharma Ltd. | Award Stock Option (right ot buy) | 20,000 | - | - | Direct |
| Feb 2, 2026 |  ALLO Allogene Therapeutics, Inc. | Award Restricted Stock Unit | 263,033 | - | - | Direct |
| Feb 2, 2026 | ALLO Allogene Therapeutics, Inc. | Award Stock Option (Right to buy) | 929,913 | - | - | Direct |
| Aug 26, 2025 | URGN UroGen Pharma Ltd. | Award Stock Option (right ot buy) | 20,000 | - | - | Direct |
| Jun 20, 2025 |  KRON Kronos Bio, Inc. | Tender Offer | 679,575 | $0.57 | $387,358 | Indirect |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | Tender Offer | 2,765,314 | $0.57 | $1,576,229 | Indirect |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | Disposition Stock Option (Right to Buy) | 20,600 | - | - | Direct |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | Disposition Stock Option (Right to Buy) | 34,000 | - | - | Direct |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | Disposition Stock Option (Right to Buy) | 34,000 | - | - | Direct |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | Disposition Stock Option (Right to Buy) | 34,000 | - | - | Direct |
1-10 of 11 transactions